GPR39 antagonists (Omeros)

N/A

Report date: 2025/01/26 18:29:34
NME

Base Information

Drug NameGPR39 antagonists (Omeros)
Drug Alias NameGPCR39 antagonists (Omeros)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 39 antagonists
TargetsG-protein coupled receptor 39
Therapy Area/IndicationsDiabetes Mellitus, Type 2Carcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsCarcinoma, Squamous Cell

Other Information

ATC CodeN/A
Related LinksN/A